Defending Doctors

7 August 2019

Regulatory proceedings: no longer least said, soonest mended

The Divisional Court (the Court), consisting of Lord Justice Hickinbottom and Mr Justice Butcher, considered the poignant topic of whether a fitness to practise panel can draw adverse inferences from a doctor’s failure to give evidence at a hearing in R (on the application of Kuzmin) v General Medical Council [2019] EWHC 2129 (Admin)

Shannett Thompson

9 July 2019

Analysing the conclusions of the gross negligence manslaughter review

Shannett Thompson, senior associate at Kingsley Napley, considers the background to the independent review of gross negligence manslaughter and culpable homicide (review) commissioned by the General Medical Council (GMC) and highlights its key recommendations. This article was first published on Lexis®PSL Corporate Crime on 4 July 2019. 

 

Shannett Thompson

3 July 2019

Reflective practice: benefits and a welcome reassurance

The eight healthcare regulators have issued a joint statement to encourage practitioners to engage and adopt reflective practice in a useful and meaningful way. The statement, which can be found here, has also been produced to try to allay any remaining fears that, following the Bawa-Garba case, reflective pieces will be held against practitioners in fitness to practise proceedings. Shannett Thompson and Claire Parry share a useful reminder and welcomed reassurance in support of reflective practice. 

Claire Parry

4 June 2019

The cannabis industry is clearly in flux

Following on from our previous blog Confused, Bewildering, Dubious? Cannabidiol in food and drinks: What does the future hold? - let’s get back to basics.

There 113 identified cannabidiols aka CBD’s found in the cannabis plant. There is much debate around the efficacy of CBD oil that does not contain the active ingredient, tetrahydrocannabinol (THC). THC is known to be the principle psychoactive constituent of cannabis.

Shannett Thompson

25 April 2019

Confused, Bewildering, Dubious? Cannabidiol in food and drinks: What does the future hold?

Last October, the EU Novel Foods Committee met to consider the evidence on certain hemp derived products, including Cannabidiol [CBD], to evaluate whether they had been widely used for human consumption within the EU prior to the 15th of May 1997, that being the date upon which the original “Novel Food” regulation, (EC) 258/97 came into force.

Shannett Thompson

Skip to content Home About Us Insights Services Contact Accessibility